These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35040901)

  • 1. Antiplatelet Therapy in Patients With COVID-19-More Is Less?
    Spaetgens B; Nagy M; Ten Cate H
    JAMA; 2022 Jan; 327(3):223-224. PubMed ID: 35040901
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 mortality in patients on anticoagulants and antiplatelet agents.
    Sivaloganathan H; Ladikou EE; Chevassut T
    Br J Haematol; 2020 Aug; 190(4):e192-e195. PubMed ID: 32584423
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study.
    Zhou J; Lee S; Guo CL; Chang C; Liu T; Leung KSK; Wai AKC; Cheung BMY; Tse G; Zhang Q
    Pharmacol Res; 2021 Mar; 165():105473. PubMed ID: 33524539
    [No Abstract]   [Full Text] [Related]  

  • 4. Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections.
    Otto CM
    Heart; 2022 Jan; 108(2):83-85. PubMed ID: 34937799
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on "Pre-hospital antiplatelet medication use on COVID-19 disease severity".
    Nadeem A; Ejaz Z
    Heart Lung; 2022; 55():164-165. PubMed ID: 35537878
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor.
    Nourmohammadi H; Azami G; Taghinezhad F; Shafiei E
    Cancer Invest; 2021 Mar; 39(3):217-218. PubMed ID: 33399484
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.
    Kow CS; Hasan SS
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):114-115. PubMed ID: 32933883
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications From Clinical Features to Pathologic Findings.
    Zhou X; Li Y; Yang Q
    Circulation; 2020 Jun; 141(22):1736-1738. PubMed ID: 32298134
    [No Abstract]   [Full Text] [Related]  

  • 9. Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era.
    Mahajan K; Batra A
    Indian Heart J; 2020; 72(3):209-211. PubMed ID: 32768026
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual arterial thrombotic events in Covid-19 patients.
    de Roquetaillade C; Chousterman BG; Tomasoni D; Zeitouni M; Houdart E; Guedon A; Reiner P; Bordier R; Gayat E; Montalescot G; Metra M; Mebazaa A
    Int J Cardiol; 2021 Jan; 323():281-284. PubMed ID: 32918938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Data and the Covid-19 Pandemic Mandate a Rethink of Antiplatelet Strategies in Patients With TIA or Minor Stroke Associated With Atherosclerotic Carotid Stenosis.
    Naylor AR; McCabe DJH
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):861-865. PubMed ID: 32362487
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
    Viecca M; Radovanovic D; Forleo GB; Santus P
    Pharmacol Res; 2020 Aug; 158():104950. PubMed ID: 32450344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preinfection Anticoagulation/Antiplatelet Therapy Does Not Influence the Outcome of COVID-19 Disease in Hospitalized Patients.
    Kaur J; Mohammed YN; Lal A; Kulkarni M; Pulipati P; Dixit P; Lee Y; Abdou A; Jehangir Q; Ibrahim M; Mandeel MN; Qamar M; Duong J
    Am J Ther; 2023 Jul-Aug 01; 30(4):e394-e396. PubMed ID: 35438651
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19.
    Giannis D; Barish MA; Goldin M; Cohen SL; Kohn N; Gianos E; Chatterjee S; Lesser M; Coppa K; Hirsch JS; McGinn T; Spyropoulos AC;
    J Thromb Thrombolysis; 2021 May; 51(4):897-901. PubMed ID: 33665766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction.
    Akşit E; Kırılmaz B; Gazi E; Aydın F
    Balkan Med J; 2020 Jun; 37(4):233-233. PubMed ID: 32326691
    [No Abstract]   [Full Text] [Related]  

  • 16. Simple demographic characteristics and laboratory findings on admission may predict in-hospital mortality in patients with SARS-CoV-2 infection: development and validation of the covid-19 score.
    Obremska M; Pazgan-Simon M; Budrewicz K; Bilaszewski L; Wizowska J; Jagielski D; Jankowska-Polanska B; Nadolny K; Madowicz J; Zuwala-Jagiello J; Zysko D; Banasiak W; Simon K
    BMC Infect Dis; 2021 Sep; 21(1):945. PubMed ID: 34521357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.
    McCullough PA; Kelly RJ; Ruocco G; Lerma E; Tumlin J; Wheelan KR; Katz N; Lepor NE; Vijay K; Carter H; Singh B; McCullough SP; Bhambi BK; Palazzuoli A; De Ferrari GM; Milligan GP; Safder T; Tecson KM; Wang DD; McKinnon JE; O'Neill WW; Zervos M; Risch HA
    Am J Med; 2021 Jan; 134(1):16-22. PubMed ID: 32771461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital mortality after pre-treatment with antiplatelet agents or oral anticoagulants and hematoma evacuation of intracerebral hematomas.
    Stein M; Misselwitz B; Hamann GF; Kolodziej M; Reinges MH; Uhl E
    J Clin Neurosci; 2016 Apr; 26():42-5. PubMed ID: 26690758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.
    Foerch C; Sitzer M; Steinmetz H; Neumann-Haefelin T
    Stroke; 2006 Aug; 37(8):2165-7. PubMed ID: 16809556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events.
    Chirumbolo S
    Clin Appl Thromb Hemost; 2021; 27():10760296211020829. PubMed ID: 34036839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.